山东新华医疗器械股份有限公司2024年年度权益分派实施公告

Core Viewpoint - The company announces the implementation of its annual profit distribution plan for 2024, which includes a cash dividend of 0.25 yuan per share, approved by the shareholders' meeting on June 3, 2025 [2][4]. Distribution Details - The cash dividend of 0.25 yuan per share (including tax) will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, after the market closes on the registration date [3][4]. - The total cash dividend to be distributed amounts to 151,669,479.75 yuan, based on the company's total share capital of 606,677,919 shares [4]. Implementation Method - The dividend will be distributed through the clearing system of the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, to shareholders who have completed designated transactions [5]. - For the shareholder Shandong Yiyang Health Industry Development Group Co., Ltd., the cash dividend will be distributed directly by the company [6]. Taxation Policies - For individual shareholders holding unrestricted shares, dividends are subject to different tax treatments based on the holding period, with a maximum tax rate of 20% for shares held for less than one month [9]. - For restricted shares, the tax treatment is similar, with a tax rate of 10% for shares held between one month and one year, and no tax for shares held over one year [10]. - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net dividend of 0.225 yuan per share [11].